Presented By ANISH JOHN, MD
Provided by RiverMend Health Institute
Scroll to the Bottom of this Information to Begin this Course
Release date: January 26, 2017
Valid through: January 26, 2020
Topic: Internet Addiction, Internet Gaming Disorder, Treatment for Internet Gaming Disorder
Estimated Time to Complete Activity: 60 minutes
This CE activity is intended for physicians, psychiatrists, physician assistants, psychologists, and allied mental health advocates.
Internet Gaming disorder (IGD) is the only behavioral/process addiction (which was chosen over others that included work, shopping, sex, and exercise) that was included as a potential new diagnosis under ‘Conditions for further study’ in the ‘Emerging Models and Measures’ section of the 5th revision of the Diagnostic and Statistical Manual; Gambling disorder remains the only current non-substance related addictive disorder included in the formal manual. This disorder has significant importance globally, as the number of individuals who are involved in gaming has exponentially increased over the past 15 years, along with an increased awareness of associated negative outcomes. Consistent comorbidities and risk factors have been identified with IGD, and a resemblance between the neural mechanisms underlying substance use disorders and IGD has been described. In addition to the proposed criteria, this presentation will review these aforementioned factors, along with its relevance in today’s constantly evolving society, available treatments and areas for further research.
Upon completion of this activity, participants should be better able to:
- List the proposed DSM-5 criteria for Internet (video) gaming disorder (IGD), and discuss its prevalence, risk factors and co-morbidities
- Review the stages of addiction and examine the neurological underpinnings of IGD
- Discuss an overview of the available treatments and areas for further research
ADACGBA, Approved Continuing Education Provider
RiverMend Health Centers, a RiverMend Health LLC entity, maintains responsibility for this program and its content. RiverMend Health LLC is a ADACGBA Approved Continuing Education Provider and may offer ADACBGA approved hours for events that meet ADACBGA requirements. Provider #15-55-03-916.
ADACBGA Continuing Education Units Awarded: 1.0
NAADAC, The Association for Addiction Professionals
RiverMend Health Institute is a NAADAC Approved Continuing Education Provider and may offer NAADAC- National Certification Commission approved hours for events that meet NAADAC requirements. Provider # 867.
NAADAC Continuing Education Units awarded: 1.0
NBCC, National Board of Certified Counselors
RiverMend Health is an NBCC-Approved Continuing Education Provider (ACEP™) and may offer NBCC approved clock hours for events that meet NBCC requirements. The ACEP solely is responsible for all aspects of the program. Provider #6573.
NBCC CE credit Awarded: 1.0
CBBS, California Board of Behavioral Sciences
This course meets the qualifications for continuing education credit for MFTs, LPCCs, LEPs and/or LCSWs as required by the California Board of Behavioral Sciences. RiverMend Health Institute Provider #4688.
CBBS CE credit awarded: 1.0
CDR, Commission on Dietetic Registration
RiverMend Health Institute is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians registered (CDR). Registered dietitians (RDs) and dietetic technicians registered (DTRs) will receive continuing professional education units (CPEUs) for the completion of this program. CDR Provider #R1656.
CDR CPEU awarded: 1.0
ANISH JOHN, MD
Dr. Anish John is the Associate Medical Director for the Positive Sobriety Institute, where he oversees care for patients in the partial hospitalization and intensive outpatient programs. A board-certified psychiatrist, Dr. John conducts patient evaluations, develops treatment plans based on bio-psycho-social clinical formulations, co-leads a multidisciplinary team and develops new programs to continue to enhance patient care.
Dr. John completed his psychiatric residency in New York, with clinical responsibilities at multiple sites including Creedmoor Psychiatric Center and Columbia University Medical Center/New York Presbyterian Hospital. During his training he worked along the continuum of acute to chronic psychiatric illnesses, with a strong focus on psychodynamic therapy, in addition to pharmacological modalities. He served as chief resident at Creedmoor Psychiatric Center, and was the recipient of the Conrad Apgar Herr Resident of the Year Award. He completed his clinical fellowship in Addiction Psychiatry at Mount Sinai Beth Israel Medical Center in New York City.
Dr. John views addiction as a complex disease, not a personal or moral shortcoming. He takes a holistic approach to healing, considering past traumas, personality profiles and co-occurring medical and psychiatric conditions while developing individualized treatment plans.
Disclosures of Conflicts of Interest
- No financial relationships relevant to this field of study.
Instructions for Participation and Credit
There are no fees for participating and receiving credit for this activity. During the accredited period, participants must read the learning objectives and faculty disclosures; study the educational activity; and complete the post-test and the evaluation form. If you pass the post-test and complete the evaluation, your certificate will be available immediately for download in PDF format.
Hardware and Software Requirements
Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. You will need a PDF viewer such as Adobe Reader to view PDF files.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.